Acta Cryst. (2005). E61, m738-m739 Gao et al. [V(C 14 H 9 N 3 O 4 )(C 13 HNO 3 )O] m739 Figure 1 ORTEPIII (Burnett & Johnson, 1996) molecular view of (I), with the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level. H atoms have been omitted for clarity.
(N-Benzoyl-N-phenylhydroxaminato-κ2O,O′)(salicylaldehyde isonicotinoylhydrazonato-κ3O,N,N′)vanadium(IV) hexane hemisolvate
✍ Scribed by Gao, Shan ;Huo, Li-Hua ;Zhao, Hui ;Ng, Seik Weng
- Publisher
- International Union of Crystallography
- Year
- 2004
- Tongue
- English
- Weight
- 215 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Single-crystal X-ray study T = 295 K Mean '(C±C) = 0.003 A Ê Disorder in main residue R factor = 0.036 wR factor = 0.110 Data-to-parameter ratio = 12.6 For details of how these key indicators were automatically derived from the article, see http://journals.iucr.org/e.
Single-crystal X-ray study T = 293 K Mean '(C±C) = 0.005 A Ê Disorder in solvent or counterion R factor = 0.051 wR factor = 0.135 Data-to-parameter ratio = 18.0 For details of how these key indicators were automatically derived from the article, see http://journals.iucr.org/e.
The V V atom in the title complex, [V(C 16 H 12 C 12 N 2 O 4 )-(C 13 H 10 NO 2 )O], is coordinated by two O atoms and one N atom of the tridentate hydrazone ligand, and by two O atoms of the bidentate hydroxamate co-ligand, thus de®ning a distorted octahedral VO(ONO)(ON) geometry.